Senior Director, Global Regulatory Policy

Bristol Myers Squibb•Princeton, NJ

About The Position

The Senior Director, Global Regulatory Policy provides strategic leadership in shaping, advancing, and advocating for Bristol Myers Squibb’s global regulatory policy priorities. The role anticipates emerging trends, assesses changes in the global regulatory environment, and translates complex scientific, technological, and policy developments into actionable insights to inform portfolio, program, and enterprise-level decisions. It collaborates across functions to develop and advance BMS regulatory policy positions, drawing on expertise in regulatory affairs, scientific policy, and the global regulatory landscape. A core area of responsibility is digital health regulatory policy. The Senior Director leads BMS’s policy strategy for digital health technologies, data-driven innovation, and emerging technologies influencing drug development and regulatory decision-making. This includes software as a medical device, digital therapeutics, digital biomarkers and endpoints, AI and machine learning, decentralized and hybrid trials, wearables and remote data capture, real-world data and evidence, diagnostics, combination products with digital components, and data privacy, cybersecurity, interoperability, and governance. The role also sets global strategy for scientific and regulatory intelligence, aligned with enterprise priorities and portfolio needs. It translates scientific, regulatory, policy, and competitor developments into insights, impact assessments, scenarios, and recommendations for senior decision-makers; connects intelligence to portfolio and program decisions; and advances regulatory science capabilities through AI, digitalization, data integration, and knowledge platforms. The position strengthens scientific exchange and foresight through internal and external expert networks and drives regulatory scientific thought leadership and publications.

Requirements

  • Bachelor’s degree required.
  • Minimum 15 years of experience in pharma or academic pharmaceutical science.
  • Background should include MD, PharmD, and an advanced degree (PhD) in life and health.
  • Significant experience in the pharmaceutical, biotechnology, or healthcare sector, ideally in regulatory affairs, drug development, regulatory science, intelligence, portfolio strategy, digital health, or a closely related field.
  • Strong understanding of the end-to-end R&D and regulatory value chain and ability to connect external developments to portfolio, program, and business implications.
  • Demonstrated experience in scientific or regulatory intelligence, horizon scanning, impact assessment, scenario development, or strategic decision support.
  • Proven ability to influence senior stakeholders and communicate complex scientific and regulatory topics clearly, with executive-level judgment.
  • Experience building networks and productive partnerships across functions, geographies, and external stakeholders.
  • Global enterprise mindset, scientific credibility, and ability to turn complexity into clear strategic opportunities.
  • Extensive leadership experience, including leading global, cross-functional, or highly specialized teams and developing talent and capabilities.

Nice To Haves

  • Advanced scientific degree preferred, such as a Master’s, PhD, PharmD, or BSN.
  • Experience in digital health regulatory policy, including software as a medical device, digital therapeutics, digital biomarkers or endpoints, AI and machine learning, decentralized trials, wearables, real-world data and evidence, diagnostics, or digitally enabled combination products.

Responsibilities

  • Monitor and interpret evolving FDA, EMA, and other global health authority frameworks, guidance, and legislation related to digital health and emerging technologies.
  • Engage with regulators, industry trade associations, standards bodies, and other external stakeholders to shape policy and advocate for science-based, innovation-enabling approaches.
  • Ensure BMS digital health and AI strategies account for regulatory expectations early in development.
  • Set global strategy for scientific and regulatory intelligence in alignment with priorities, portfolio needs, and enterprise strategy.
  • Translate scientific, regulatory, policy, and competitor developments into concise insights, impact assessments, scenarios, and actionable recommendations for senior decision-makers.
  • Connect intelligence to portfolio and program decisions, including opportunities to accelerate development, strengthen regulatory strategies, and reduce regulatory uncertainty.
  • Drive innovation in regulatory science capabilities using AI, digitalization, data integration, and fit-for-purpose knowledge platforms, including AI-enabled regulatory intelligence tools and newsletters.
  • Explore regulatory scientific solutions aligned with the portfolio, business priorities, and Global Regulatory expertise areas.
  • Strengthen scientific exchange and foresight through internal subject-matter experts, external expert networks, academia, health authorities, and industry ecosystems.
  • Drive regulatory scientific thought leadership activities and scientific publications.
  • Lead global, cross-functional, or specialized teams and develop talent and capabilities.

Benefits

  • Comprehensive benefit plans, including wellbeing support, retirement and financial protection benefits, and medical, dental, vision, life, and disability insurance.
  • Flexible Time Off without a set accrual limit for eligible U.S.-based exempt employees, subject to manager approval.
  • 11 paid company holidays each year.
  • For eligible non-exempt employees, RayzeBio employees, and employees in Puerto Rico: 160 hours of paid vacation annually for new hires, 11 paid company holidays, and 3 optional holidays.
  • Depending on eligibility, paid sick leave, up to two paid volunteer days per year, summer hours flexibility, and leaves of absence for medical, personal, parental, caregiver, bereavement, or military needs.
  • Eligible employees may receive an annual Global Shutdown between Christmas Day and New Year’s Day.
  • Potential eligibility for additional discretionary incentive cash and stock opportunities.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service